These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 265741)

  • 1. Anthracycline cardiotoxicity and acute myelogenous leukaemia.
    Al-Ismail SA; Parry DH; Whittaker JA
    Br Med J; 1977 Mar; 1(6064):815. PubMed ID: 265741
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sudden death in leukemic patients treated with doxorubicin].
    Lacasse Y; Bolduc P
    Can J Cardiol; 1992; 8(1):53-6. PubMed ID: 1617512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daunorubicin and adriamycin in the treatment of leukemia.
    Klener P; Donner L; Kozená J
    Neoplasma; 1973; 20(1):87-96. PubMed ID: 4573873
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
    Rizzari C; Santamaria M; Galli MA; Jankovic M; Uderzo C
    Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic assessment of anthracycline cardiotoxicity in children.
    Lewis AB; Pilkington R; Takahashi M; Siegel SE
    Med Pediatr Oncol; 1978; 5(1):167-75. PubMed ID: 745585
    [No Abstract]   [Full Text] [Related]  

  • 7. Daunorubicin or doxorubicin in acute myelogenous leukemia?
    Gale RP; Foon KA
    Leukemia; 1988 Apr; 2(4):209-10. PubMed ID: 3163077
    [No Abstract]   [Full Text] [Related]  

  • 8. The cardiotoxicity of adriamycin and daunomycin in children.
    Gilladoga AC; Manuel C; Tan CT; Wollner N; Sternberg SS; Murphy ML
    Cancer; 1976 Feb; 37(2 Suppl):1070-8. PubMed ID: 1253124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 1 and 2 trial of rubidazone in patients with acute leukemia.
    Benjamin RS; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
    Cancer Res; 1977 Dec; 37(12):4623-8. PubMed ID: 270389
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac ultrastructural changes induced by daunorubicin therapy.
    Buja LM; Ferrans VJ; Mayer RJ; Roberts WC; Henderson ES
    Cancer; 1973 Oct; 32(4):771-88. PubMed ID: 4270890
    [No Abstract]   [Full Text] [Related]  

  • 11. Anthracycline cardiomyopathy in children: report of two cases.
    Mosijczuk AD; Ruymann FB; Mease AD; Bernier RD
    Cancer; 1979 Nov; 44(5):1582-7. PubMed ID: 291472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute myeloblastic leukaemia with RP 22050.
    Jacquillat C; Weil M; Gemon MF; Izrael V; Schaison G; Boiron M; Bernard J
    Br Med J; 1972 Nov; 4(5838):468-9. PubMed ID: 4510816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serial determination of anthracycline poisoning in children].
    Stein JI; Langevin A; Benson LN; Souza MD; Wilson G; Chan H
    Wien Klin Wochenschr; 1989 Jan; 101(1):45-8. PubMed ID: 2913725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
    Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
    J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Daunomycin and atrial fibrillation].
    Fuster Siebert M; Fernández Iglesias A; Couselo Sánchez JM; Gallego García D; Iglesias Diz JL; Alvez González F
    An Esp Pediatr; 1983 Nov; 19(5):415-6. PubMed ID: 6581751
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acute granulocytic leukemias.
    Bernard J; Weil M; Jacquillat C
    Annu Rev Med; 1974; 25():39-51. PubMed ID: 4596234
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythroleukaemia and daunorubicin-induced cardiotoxicity in a young boy.
    Malhotra OP; Talwar KK; Chopra P; Kumar R
    Br J Clin Pract; 1990 Dec; 44(12):633-4. PubMed ID: 2102164
    [No Abstract]   [Full Text] [Related]  

  • 18. Daunorubicin in acute myelocytic leukaemia.
    Malpas JS; Scott RB
    Lancet; 1969 Mar; 1(7592):469-70. PubMed ID: 4179532
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed cardiac toxicity from anthracycline therapy.
    Steinherz L; Steinherz P
    Pediatrician; 1991; 18(1):49-52. PubMed ID: 1983861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
    Wheeler DM
    Cancer Chemother Rep; 1975; 59(2 Pt 1):258-9. PubMed ID: 1149002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.